From https://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
Pfizer
Pfizer, based in New York, paid $2.3 billion in fines and penalties in 2009 to resolve allegations that it illegally promoted some of its drugs. A subsidiary also pleaded guilty to felony charges of improperly marketing the anti-inflammatory Bextra. Its top-selling drug Lipitor went off patent in early 2012.
Pfizer began reporting payments for speaking, consulting, research, meals, travel and educational items in July 2009. It has not changed its reporting format in any material way since then.
Pfizer's 2013 U.S. sales: $17 billion. Source: IMS Health.
See all Pfizer payments, or visit Pfizer's transparency page.
Notable drugs
- Lyrica (epilepsy, post-herpetic neuralgia and diabetic, peripheral neuropathy, fibromyalgia)
- Celebrex (arthritis pain and inflammation, acute pain)
- Viagra (erectile dysfunction)
- Zyvox (bacterial infections)
- Sutent (late-stage kidney cancer, gastrointestinal stromal tumor)
- Premarin family (menopause)
- Chantix (smoking cessation)
- BeneFIX (hemophilia)
- Effexor XR (depression and certain anxiety disorders)
- Pristiq (depression)
Payment Reports
2009 July to Dec.
Avg. Quarterly | Total | |
---|---|---|
Research | $9,033,966 | $18,067,931 |
Speaking | $6,275,024 | $12,550,047 |
Consulting | $2,264,425 | $4,528,850 |
Travel | $848,655 | $1,697,310 |
Meals | $460,303 | $920,605 |
Items, Gifts | $6,205 | $12,409 |
$18,888,576 | $37,777,152 |
2010 Jan. to Dec.
Avg. Quarterly | Total | |
---|---|---|
Research | $27,279,667 | $109,118,666 |
Speaking | $8,595,312 | $34,381,249 |
Meals | $4,494,498 | $17,977,991 |
Consulting | $2,213,076 | $8,852,303 |
Travel | $1,440,352 | $5,761,408 |
Items, Gifts | $429,357 | $1,717,429 |
$44,452,262 | $177,809,046 |
2011 Jan. to Dec.
Avg. Quarterly | Total | |
---|---|---|
Research | $36,154,602 | $144,618,409 |
Speaking | $5,453,534 | $21,814,137 |
Meals | $3,227,817 | $12,911,269 |
Consulting | $2,407,883 | $9,631,531 |
Travel | $1,203,170 | $4,812,678 |
Items, Gifts | $333,507 | $1,334,027 |
$48,780,513 | $195,122,051 |
2012 Jan. to Dec.
Avg. Quarterly | Total | |
---|---|---|
Research | $36,045,444 | $144,181,774 |
Consulting | $2,194,713 | $8,778,853 |
Speaking | $2,073,078 | $8,292,310 |
Meals | $1,968,750 | $7,874,999 |
Travel | $697,347 | $2,789,386 |
Items, Gifts | $225,317 | $901,268 |
$43,204,648 | $172,818,590 |
2013 Jan. to Dec.
Avg. Quarterly | Total | |
---|---|---|
Research | $31,430,980 | $125,723,918 |
Speaking | $3,148,263 | $12,593,052 |
Consulting | $2,495,897 | $9,983,588 |
Meals | $2,449,001 | $9,796,003 |
Travel | $817,771 | $3,271,085 |
Items, Gifts | $72,874 | $291,496 |
$40,414,786 | $161,659,142 |
Total Payments by State
State | Total |
---|---|
California | $105,222,860 |
Florida | $71,500,286 |
Texas | $62,332,074 |
New York | $45,575,296 |
Ohio | $32,654,789 |
Pennsylvania | $32,137,760 |
Massachusetts | $31,290,630 |
North Carolina | $26,165,304 |
Kansas | $23,286,119 |
Georgia | $18,036,473 |
Illinois | $17,869,562 |
Tennessee | $17,306,257 |
Maryland | $16,302,002 |
Michigan | $16,100,910 |
Missouri | $16,087,960 |
New Jersey | $15,188,016 |
Kentucky | $13,765,239 |
Minnesota | $13,657,806 |
Connecticut | $12,589,347 |
Utah | $12,102,884 |
Colorado | $11,644,444 |
Washington | $11,372,607 |
Alabama | $10,836,966 |
Arizona | $10,153,508 |
Virginia | $9,876,975 |
South Carolina | $9,622,669 |
Indiana | $8,651,830 |
Rhode Island | $8,077,345 |
Wisconsin | $7,341,685 |
Louisiana | $6,761,923 |
Oregon | $6,712,531 |
Nebraska | $4,718,878 |
Oklahoma | $4,661,692 |
Arkansas | $4,592,858 |
Nevada | $3,678,103 |
District of Columbia | $3,591,327 |
Iowa | $3,114,559 |
North Dakota | $2,780,659 |
Puerto Rico | $2,656,114 |
Mississippi | $2,324,288 |
New Hampshire | $2,082,554 |
West Virginia | $1,991,754 |
Idaho | $1,761,599 |
New Mexico | $1,529,419 |
Hawaii | $981,975 |
Delaware | $951,279 |
Maine | $905,262 |
South Dakota | $798,770 |
Vermont | $647,299 |
Montana | $371,597 |
Wyoming | $342,152 |
Alaska | $288,082 |
[Unknown State] | $190,449 |
What Companies Disclose
See which services pharmaceutical companies report paying health practitioners for.
Big Pharma’s Big Fines
Drug companies have paid billions to the Department of Justice to resolve allegations of health care fraud. See some of the biggest settlements.